Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone

Detection of specific chromosomal abnormalities by FISH and metaphase cytogenetics allows risk stratification in multiple myeloma; however, gene expression profiling (GEP) based signatures may enable more specific risk categorization. We examined the utility of 2 GEP-based risk stratification system...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kumar, Shaji K., Uno, Hajime, Jacobus, Susanna J., Wier, Scott A. Van, Ahmann, Greg J., Henderson, Kimberly J., Callander, Natalie S., Haug, Jessica L., Siegel, David S., Greipp, Philip R., Fonseca, Rafael, Rajkumar, S. Vincent
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2011
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3204907/
https://ncbi.nlm.nih.gov/pubmed/21860025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-03-342089
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados